Skip to main content
TipRanks
Go Ultimate75% OFF

Aarti Drugs Limited (AARTIDRUGS) Financial Statements

3 Followers

Aarti Drugs Limited Financial Overview

Aarti Drugs Limited's market cap is currently ₹45.80B. The company's EPS TTM is ₹21.35; its P/E ratio is 19.99; and it has a dividend yield of 0.40%. Aarti Drugs Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 25.65B₹ 23.87B₹ 25.29B₹ 27.16B₹ 24.89B
Gross Profit₹ 7.50B₹ 8.45B₹ 8.51B₹ 3.69B₹ 3.89B
Operating Income₹ 2.42B₹ 7.33B₹ 2.69B₹ 2.65B₹ 2.88B
EBITDA₹ 3.12B₹ 2.87B₹ 3.25B₹ 3.12B₹ 3.44B
Net Income₹ 1.95B₹ 1.68B₹ 1.71B₹ 1.66B₹ 2.05B
Balance Sheet
Cash & Short-Term Investments₹ 242.80M₹ 226.10M₹ 89.28M₹ 211.70M₹ 343.81M
Total Assets₹ 28.15B₹ 25.75B₹ 24.32B₹ 24.21B₹ 22.08B
Total Debt₹ 5.77B₹ 6.15B₹ 5.64B₹ 6.09B₹ 5.43B
Net Debt₹ 5.68B₹ 6.08B₹ 5.58B₹ 6.00B₹ 5.21B
Total Liabilities₹ 12.66B₹ 12.05B₹ 11.50B₹ 12.29B₹ 11.72B
Stockholders' Equity₹ 15.49B₹ 13.69B₹ 12.82B₹ 11.92B₹ 10.36B
Cash Flow
Free Cash Flow₹ 490.90M₹ 674.20M₹ 1.33B₹ -304.70M₹ -823.39M
Operating Cash Flow₹ 2.22B₹ 2.45B₹ 3.59B₹ 1.34B₹ 696.36M
Investing Cash Flow₹ -1.75B₹ -1.65B₹ -2.24B₹ -1.64B₹ -1.49B
Financing Cash Flow₹ -451.40M₹ -821.20M₹ -1.36B₹ 165.40M₹ 920.25M

Currency in INR

Aarti Drugs Limited Earnings and Revenue History

010B20B30B4 %8 %12 %16 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin

Aarti Drugs Limited Liabilities to Assets

010B20B30B40 %50 %60 %70 %LiabilitiesLiabilities to Assets2017201820192020202120222023202420252026AssetsLiabilitiesLiabilities to Assets

Aarti Drugs Limited Cash Flow

-4B-2B02B4B2017201820192020202120222023202420252026OperatingInvestingFinancing

Aarti Drugs Limited Forecast EPS vs Actual EPS

45678Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27EPS EstimateBeatMiss